| XABE25011 | 2,4-Dichloro-5-Fluoropyrimidine | 2927-71-1 | Abemaciclib |
| XABE25012 | N-Propan-2-ylacetamide | 1118-69-0 | Abemaciclib |
| XABE25013 | 5-((4-Ethylpiperazin-1-yl)Methyl)Pyridin-2-Amine | 1180132-17-5 | Abemaciclib |
| XABE25014 | 6-Bromo-4-Fluoro-1-Isopropyl-2-Methyl-1H-Benzo[d]imidazole | 1231930-33-8 | Abemaciclib |
| XABE25015 | 6-(2-chloro-5-fluoropyrimidin-4-yl)-4-fluoro-2-methyl-1-propan-2-ylbenzimidazole | 1231930-42-9 | Abemaciclib |
| XACA25011 | (4-(Pyridin-2-Ylcarbamoyl)Phenyl)Boronic Acid | 850568-25-1 | Acalabrutinib |
| XACA25012 | N-(Pyridin-2-yl)-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-yl)Benzamide) | 1383385-64-5 | Acalabrutinib |
| XACA25013 | (S)-Benzyl 2-(8-Amino-1-Bromoimidazo[1,5-a]Pyrazin-3-yl)Pyrrolidine-1-Carboxylate | 1420478-88-1 | Acalabrutinib |
| XAFO25011 | 4-Acetyl-1-Naphthoic Acid | 131986-05-5 | Afoxolaner |
| XAFO25012 | 1-[3-Chloro-5-Trifluoromethylphenyl]-2,2,2-Trifluoroethanone | 1125812-58-9 | Afoxolaner |
| XAFO25013 | 4-[5-[3-Chloro-5-(Trifluoromethyl)Phenyl]-5-(Trifluoromethyl)-4,5-Dihydro-1,2-Oxazol-3-yl]Naphthalene-1-Carboxylic Acid | 1308362-48-2 | Afoxolaner |
| XAPR26011 | 5-(4-bromophenyl)-4,6-dichloropyrimidine | 146533-41-7 | Aprocitentan |
| XARO25011 | 5-Acetylthiophene-2-carboxylic acid | 4066-41-5 | Arotinolol |
| XARO25012 | 5-Acetylthiophene-2-carboxamide | 68257-89-6 | Arotinolol |
| XARO25013 | 5-(2-Sulfanylidene-3H-1,3-thiazol-4-yl)thiophene-2-carboxamide | 52560-89-1 | Arotinolol |
| XASC25011 | Methyl 5-bromo-6-chloropyridine-3-carboxylate | 78686-77-8 | Asciminib |
| XAVA26011 | (S)-2-methylpropane-2-sulfinamide | 343338-28-3 | Avapritinib |
| XAVA26012 | ethyl 2-chloropyrimidine-5-carboxylate | 89793-12-4 | Avapritinib |
| XAVA26013 | bis(ditert-butyl(cyclopenta-1,3-dien-1-yl)phosphane);iron(2+) | 84680-95-5 | Avapritinib |
| XAVA25011 | 4-(4-Chloro-2-Thienyl)-2-Thiazolamine | 570407-10-2 | Avatrombopag |
| XBAL26011 | 7,8-difluoro-6H-benzo[c][1]benzothiepin-11-one | 2136287-66-4 | Baloxavir |
| XBAR25011 | 4-(1H-Pyrazol-4-yl)-7-((2-(Trimethylsilyl)Ethoxy)Methyl-7H-Pyrrolo[2,3-d]Pyrimidine | 941685-27-4 | Baricitinib |
| XBAR25012 | Tert-Butyl 3-(Cyanomethylene)Azetidine-1-Carboxylate | 1153949-11-1 | Baricitinib |
| XBAR25013 | 2-(Azetidin-3-ylidene)acetonitrile hydrochloride | 1314910-43-4 | Baricitinib |
| XBRI25011 | (R)-Dihydro-4-Propyl-2(3H)-Furanone | 63095-51-2 | Brivaracetam |
| XBRI25012 | (R)-N-((S)-1-Amino-1-Oxobutan-2-yl)-3-(Chloromethyl) Hexanamide | 2052297-74-0 | Brivaracetam |
| XCAM26011 | N-methoxymethanamine;hydrochloride | 6638-79-5 | Camlipixant |
| XCAP25011 | (2R)-3-Acetylthio-2-Methylpropionyl Chloride | 74345-73-6 | Captopril |
| XCAP25012 | (D-3-Acetylthio-2-methylpropanoic acid) | 76497-39-7 | Captopril |
| XCEN25011 | 1,1'-Carbonyldiimidazole | 530-62-1 | Cenobamate |
| XDAB25011 | 2,2,2-Trimethylthioacetamide | 630-22-8 | Dabrafenib Mesylate |
| XDAB25012 | 2,6-Difluorobenzenesulfonyl Chloride | 60230-36-6 | Dabrafenib Mesylate |
| XDAB25013 | 2-Chloro-4-Methylpyrimidine | 13036-57-2 | Dabrafenib Mesylate |
| XDAB25014 | 3-Amino-2-FluoroBenzoic Acid Methyl Ester | 1195768-18-3 | Dabrafenib Mesylate |
| XDAN25011 | 1,1,1-Trimethoxy-2-chloroethane | 74974-54-2 | Danuglipron |
| XDAN25012 | Methyl 3,4-diaminobenzoate | 36692-49-6 | Danuglipron |
| XDAN25013 | Methyl 3,4-diamino-5-bromobenzoate | 1245643-11-1 | Danuglipron |
| XDEU25011 | Ethyl 4,6-dichloropyrridazine-3-carboxylate | 679406-03-2 | Deucravacitinib |
| XDEU25012 | Lithium 4,6-dichloropyridazine-3-carboxylate hydrate | 2245111-15-1 | Deucravacitinib |
| XDEU25013 | 2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)aniline | 1609394-10-6 | Deucravacitinib |
| XDOL25011 | Methyl4-methoxyacetoacetate | 41051-15-4 | Dolutegravir |
| XDUL25011 | (S)-3-(Methylamino)-1-(2-Thienyl)-1-Propanol | 116539-55-0 | Duloxetine |
| XEDO25011 | 1-Hydroxybenzotriazole | 2592-95-2 | Edoxaban Tosylate Hydrate |
| XEDO25012 | 1-[3-(Dimethylamino)Propyl]-3-Ethylcarbodiimide Hydrochloride | 25952-53-8 | Edoxaban Tosylate Hydrate |
| XEDO25013 | 2-[(5-Chloropyridin-2-yl)Amino]-2-Oxoacetic Acid Ethyl Ester Monohydrochloride | 1243308-37-3 | Edoxaban Tosylate Hydrate |
| XEDO25014 | 5-Methyl-4,5,6,7-Tetrahydrothiazolo[5,4-c]Pyridine-2-Carboxylic Acid Hydrochloride | 720720-96-7 | Edoxaban Tosylate Hydrate |
| XEDO25015 | Tert-Butyl[(1R,2S,5S)-2-Amino-5-[(Dimethylamino)Carbonyl]Cyclohexyl]Carbamate Oxalate | 1210348-34-7 | Edoxaban Tosylate Hydrate |
| XELA25011 | N-Ethyl-2-(4-Formylphenyl)Acetamide | 2477812-42-1 | Elacestrant |
| XELA25012 | N-[2-(4-Formylphenyl)ethyl]acetamide | 61629-92-3 | Elacestrant |
| XELA25013 | 2'-Bromo-5'-methoxyacetanilide | 123027-99-6 | Elacestrant |
| XELA25014 | 7-(Benzyloxy)-3-BroMo-1,2-Dihydronaphthalene | 722536-73-4 | Elacestrant |
| XELA25015 | 1,1-DimethylethylN-ethyl-N-[2-(4-formylphenyl)ethyl]carbamate | 2384514-21-8 | Elacestrant |
| XELA25016 | 6-(2-amino-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol | 722520-36-7 | Elacestrant |
| XELA25017 | (R)-6-(2-amino-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol | 2477812-39-6 | Elacestrant |
| XELA25018 | 6-[2-(Ethylamino)-4-methoxyphenyl]-5,6,7,8-tetrahydro-2-naphthalenol | 722520-42-5 | Elacestrant |
| XELA25019 | (R)-6-(2-(ethylamino)-4-methoxyphenyl)-5,6,7,8-tetrahydronaphthalen-2-ol | 3033111-52-0 | Elacestrant |
| XELA25020 | N-(2-(6-(benzyloxy)-3,4-dihydronaphthalen-2-yl)-5-methoxyphenyl)acetamide | 2477812-37-4 | Elacestrant |
| XELA25021 | N-(2-(6-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)-5-methoxyphenyl)acetamide | 2477812-38-5 | Elacestrant |
| XENS26011 | 2-(2-bromoethyl)isoindole-1,3-dione | 574-98-1 | Ensifentrine |
| XESA25011 | 2-(Trifluoromethyl) Propiophenone | 16185-96-9 | Esaxerenone |
| XESA25012 | 1H-Pyrrole-3-Carboxylic Acid, 4-Methyl-5-[2-(Trifluoromethyl)Phenyl]-, Ethyl Ester | 1631030-76-6 | Esaxerenone |
| XFAM26011 | Sulfamide | 7803-58-9 | Famotidine |
| XFEX25011 | Methyl 5-(2,4-Difluorophenyl)-4-Methoxy-1H-Pyrrole-3-Carboxylate | 1902955-29-6 | Fexuprazan |
| XFEX25012 | 3-Fluorobenzene-1-Sulphonyl Chloride | 701-27-9 | Fexuprazan |
| XFEX25013 | 5-(2,4-Difluorophenyl)-1-((3-Fluorophenyl)Sulfonyl)-4-Methoxy-1H-Pyrrole-3-Carbaldehyde | 1902955-31-0 | Fexuprazan |
| XFEX25014 | 5-(2,4-difluorophenyl)-4-methoxy-1H-pyrrole-3-carbaldehyde | 2756367-38-9 | Fexuprazan |
| XFEZ25011 | (3R)-4-[(2,4-dimethoxyphenyl)methyl]-3-methylpiperazin-2-one | 1383146-20-0 | Fezolinetant |
| XFEZ25012 | 3-Methyl-1,2,4-thiadiazole-5-carbohydrazide | 1375066-73-1 | Fezolinetant |
| XFLU25011 | 2-AMino-N-(2,2,2-Trifluoroethyl)Acetamide Hydrochloride | 1171331-39-7 | Fluralaner |
| XFLU25012 | 3',5'-Dichloro-2,2,2-Trifluoroacetophenone | 130336-16-2 | Fluralaner |
| XFLU25013 | 4-Acetyl-2-Methylbenzoic Acid | 55860-35-0 | Fluralaner |
| XFRU25011 | 6-Hydroxy-N,2-Dimethylbenzofuran-3-Carboxamide | 638217-08-0 | Fruquintinib |
| XFRU25012 | 4-Chloro-6,7-Dimethoxyquinazoline | 13790-39-1 | Fruquintinib |
| XFRU25013 | 2-Amino-4,5-Dimethoxybenzoic Acid | 5653-40-7 | Fruquintinib |
| XGEF26011 | Guanidine hydrochloride | 50-01-1 | Gefapixant citrate |
| XGRA25011 | Tert-Butyl(4-((3-Amino-2,6-Dimethylpyridin-4-yl)Amino)Phenethyl)Carbamate | 2408731-72-4 | Grapiprant |
| XIPT25011 | 4-Methoxypyridine | 620-08-6 | Iptacopan |
| XIPT25012 | Benzyl 4-Oxo-3,4-Dihydropyridine-1(2H)-Carboxylate | 185847-84-1 | Iptacopan |
| XIPT25013 | Methyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate | 171364-80-0 | Iptacopan |
| XIPT25014 | 1,1-Dimethylethyl 4-formyl-5-methoxy-7-methyl-1H-indole-1-carboxylate | 1481631-51-9 | Iptacopan |
| XIPT25015 | Methyl 4-((2S,4S)-4-Ethoxypiperidin-2-yl)Benzoate | 1644667-61-7 | Iptacopan |
| XLEN25021 | 7-Bromo-4-chloro-1H-indazol-3-ylamine | 1626336-65-9 | Lenacapavir |
| XLEN25022 | 3-bromo-6-chloro-2-fluoroBenzonitrile | 943830-79-3 | Lenacapavir |
| XLEN25023 | 7-bromo-4-chloro-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine | 2189684-52-2 | Lenacapavir |
| XLEN25024 | (S)-1-(3,6-dibromopyridin-2-yl)-2-(3,5-difluorophenyl)ethan-1-amine | 1626481-45-5 | Lenacapavir |
| XLEN25025 | 4-chloro-7-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)-1H-indazol-3-amine | 2189684-53-3 | Lenacapavir |
| XLEN25026 | tert-butyl (S)-(1-(3-bromo-6-(3-methyl-3-(methylsulfonyl)but-1-yn-1-yl)pyridin-2-yl)-2-(3,5-difluorophenyl)ethyl)carbamate | 2189684-54-4 | Lenacapavir |
| XLIN25021 | 2,3-Difluoro-6-Methoxybenzyl Bromide | 886501-83-3 | Linzagolix |
| XLIN25022 | Dimethyl 4-Aminothiophene-2,3-Dicarboxylate | 62947-31-3 | Linzagolix |
| XLIN25023 | 4-Fluoro-2-Methoxy-5-Nitrophenol | 935286-13-8 | Linzagolix |
| XLIN25024 | Linzagolix Choline | 1321816-57-2 | Linzagolix |
| XLIN25025 | 2,3-Difluoro-6-Methoxybenzyl Chloride | 1073435-67-2 | Linzagolix |
| XLIN25026 | Dimethyl 4-Aminothiophene-2,3-Dicarboxylate Hydrochloride | 121071-71-4 | Linzagolix |
| XLIN25027 | Benzenamine, 5-[(2,3-Difluoro-6-Methoxyphenyl)Methoxy]-2-Fluoro-4-Methoxy- | 935287-59-5 | Linzagolix |
| XLUM25021 | (4aS,9bR)-6-bromo-1H,2H,3H,4H,4aH,5H,9bH-pyrido[4,3-b]indole,(2S)-2-hydroxy-2-phenylacetic acid | 1059630-13-5 | Lumateperone |
| XLUM25022 | (4aS,9bR)-Ethyl 6-bromo-5-(2-(methylamino)-2-oxoethyl)-3,4,4a,5-tetrahydro-1H-pyrido[4,3-b]indole-2(9bH)-carboxylate | 2098497-32-4 | Lumateperone |
| XLUM25023 | Ethyl2-oxo-2,3,9,10-tetrahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxaline-8(7H)-carboxylate | 313544-31-9 | Lumateperone |
| XLOX25011 | Loxoprofen | 68767-14-6 | Loxoprofen sodium |
| XMAR25011 | 4,5-Dichlorobenzene-1,2-Diamine | 5348-42-5 | Maribavir |
| XMIL25011 | (R)-2-Methylbut-3-Enoic Acid | 20626-49-7 | Milvexian |
| XMIL25012 | (5R,9S)-9-Amino-21-(Difluoromethyl)-5-Methyl-21H-3-Aza-1(4,2)-Pyridina-2(5,4)-Pyrazolacyclononaphan-4-One | 1802431-24-8 | Milvexian |
| XMIL25013 | 6-(5-Chloro-2-(4-Chloro-1H-1,2,3-Triazo-1-yl)Phenyl)Pyrimidin-4-ol | 1802430-55-2 | Milvexian |
| XMON25011 | 3-Hydroxy-4-(Trifluoromethyl)Benzonitrile | 731002-50-9 | Monepantel |
| XNEM25011 | 2-Iodo-5-Methoxybenzoic Acid | 54413-93-3 | Nemorexant |
| XNEM25012 | 5-Methoxy-2-(2H-1,2,3-Triazol-2-yl)Benzoic Acid | 1293284-55-5 | Nemorexant |
| XNEM25013 | 1H-Benzimidazole,6-Chloro-7-Methyl-2-[(2S)-2-Methyl-2-Pyrrolidinyl]-,Hydrochloride | 1788104-76-6 | Nemorexant |
| XORF25011 | 5-Bromo-1,3-dimethyl-2-fluorobenzene | 99725-44-7 | Orforglipron |
| XORF25012 | (4-Fluoro-3,5-dimethylphenyl)hydrazine HCl | 2212021-40-2 | Orforglipron |
| XORF25013 | 5-Bromoindole-2-carboxylic acid | 7254-19-5 | Orforglipron |
| XORF25014 | Ethyl 5-Bromoindole-2-carboxylate | 16732-70-0 | Orforglipron |
| XORF25015 | (S)-3-Aminobutanenitrile hydrochloride | 1073666-54-2 | Orforglipron |
| XORF25016 | 3-Fluoro-2-methylaniline | 443-86-7 | Orforglipron |
| XORF25017 | 2,5-Dibromofluorobenzene | 1435-52-5 | Orforglipron |
| XORF25018 | 4-Bromo-3-fluoro-2-methylaniline | 127408-03-1 | Orforglipron |
| XORF25019 | Tert-butyl (4S)-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-3-(2-oxo-1H-imidazol-3-yl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-5-carboxylate | 2212021-61-7 | Orforglipron |
| XORF25020 | tert-butyl N-(4-fluoro-3,5-dimethylphenyl)-N-[(2-methylpropan-2-yl)oxycarbonylamino]carbamate | 2212021-55-9 | Orforglipron |
| XORF25021 | 5-Bromo-4-fluoro-1-methyl-1H-indazole | 1784678-61-0 | Orforglipron |
| XORF25022 | (2S)-tert-Butyl 3-cyano-2-methyl-4-oxopiperidine-1-carboxylate | 2212021-56-0 | Orforglipron |
| XORF25023 | tert-butyl (S)-3-amino-2-(4-fluoro-3,5-dimethylphenyl)-4-methyl-2,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]p
yridine-5-carboxylate | 2212021-59-3 | Orforglipron |
| XORF25024 | 5-[(4S)-2,2-dimethyloxan-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4H-1,2,4-oxadiazol-3-yl)cyclopropyl]indole-2-carboxylic acid | 2212021-83-3 | Orforglipron |
| XOSI26011 | 4-fluoro-2-methoxy-5-nitroaniline | 1075705-01-9 | Osimertinib |
| XOSI26012 | 3-(2-chloropyrimidin-4-yl)-1-methylindole | 1032452-86-0 | Osimertinib |
| XOSI26013 | N,N',N'-trimethylethane-1,2-diamine | 142-25-6 | Osimertinib |
| XOSI26014 | 1-N-[2-(dimethylamino)ethyl]-5-methoxy-1-N-methyl-4-N-[4-(1-methylindol-3-yl)pyrimidin-2-yl]benzene-1,2,4-triamine | 1421372-66-8 | Osimertinib |
| XPAC25011 | [3-(2-Chloro-pyrimidin-4-yl)-phenyl]-methanol | 859517-90-1 | Pacritinib |
| XPAC25012 | 2-(2-Chloroethoxy)-5-Nitrobenzaldehyde | 110837-53-1 | Pacritinib |
| XPAC25013 | 2-((Allyloxy)Methyl)-1-(2-Chloroethoxy)-4-Nitrobenzene | 937273-31-9 | Pacritinib |
| XPAC25014 | 4-(3-(Allyloxymethyl)Phenyl)-2-Chloropyrimidine | 937273-29-5 | Pacritinib |
| XPAC25015 | 3-(Allyloxymethyl)-4-(2-(Pyrrolidin-1-yl)Ethoxy)Benzenamine | 937273-33-1 | Pacritinib |
| XPON25011 | 3-Bromoimidazo[1,2-b]Pyridazine | 18087-73-5 | Ponatinib |
| XPON25012 | 1-Methyl-4-{[4-Nitro-2-(Trifluoromethyl)Phenyl]Methyl}Piperazine | 694499-24-6 | Ponatinib |
| XPON25013 | 4-[(4-Methylpiperazin-1-yl)Methyl]-3-(Trifluoromethyl)Aniline | 694499-26-8 | Ponatinib |
| XPON25014 | 3-Ethynylimidazolo[1,2-B]Pyridazine | 943320-61-4 | Ponatinib |
| XPON25021 | Propyl isothiocyanate | 628-30-8 | Ponesimod |
| XREL25011 | 1-(3-Fluoropyridin-2-yl)-3-oxocyclobutane-1-carbonitrile | 1344145-36-3 | Reldesemtiv |
| XREM25011 | 5-Fluoro-2-methyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)aniline | 1418128-33-2 | Remibrutinib |
| XREM25012 | Tert-Butyl2-(4-amino-6-chloropyrimidin-5-yloxy)ethylmethylcarbamate | 1787294-51-2 | Remibrutinib |
| XREM25014 | 4-Cyclopropyl-2-fluorobenzoic acid | 1247927-81-6 | Remibrutinib |
| XREM25015 | Methyl 4-cyclopropyl-2-fluorobenzoate | 1613413-65-2 | Remibrutinib |
| XREM25016 | 2-Bromo-4-Fluoro-6-Nitrotoluene | 502496-33-5 | Remibrutinib |
| XRES25013 | 4-Cyclopropyl-2-Fluoro-N-(5-Fluoro-2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan
-2-yl)Phenyl)Benzamide | 1787294-47-6 | Resmetirom |
| XRIM25011 | 1-Piperidinecarboxylic Acid, 4-[(2-Amino-3-Pyridinyl)Amino]-, 1,1-Dimethylethyl Ester | 781649-86-3 | Rimegepant |
| XRIM25012 | (6S,9R)-6-(2,3-Difluorophenyl)-6,7,8,9-Tetrahydro-9-[[Tris(1-Methylethyl)Silyl]oxy]-5H-Cyclohepta[b]Pyridin-5-One | 1190363-46-2 | Rimegepant |
| XRIM25013 | (5S,6S,9R)-5-Amino-6-(2,3-Difluorophenyl)-6,7,8,9-Tetrahydro-5H-Cyclohepta[C]Pyridin-9-ol:Dihydrochloride | 1373116-07-4 | Rimegepant |
| XRIM25014 | (5S,6S,9R)-6-(2,3-difluorophenyl)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-aminedihydrochloride | 1373116-04-1 | Rimegepant |
| XRIO25011 | 1H-Pyrazolo[3,4-b]pyridine-3-carboximidamide, 1-[(2-fluorophenyl)methyl]-, hydrochloride (1:1) | 256499-19-1 | Riociguat |
| XRIO25012 | 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridine-3-carbonitrile | 256376-65-5 | Riociguat |
| XRUX25011 | 2-(Trimethylsilyl)Ethoxymethyl Chloride | 76513-69-4 | Ruxolitinib Phosphate |
| XRUX25012 | 3-Cyclopentylacrylonitrile | 591769-05-0 | Ruxolitinib Phosphate |
| XRUX25013 | Pyrazole-4-Boronic Acid Pinacol Ester | 269410-08-4 | Ruxolitinib Phosphate |
| XRUX25014 | Pyrrolo[2,3-d]Pyrimidin-4-Ol | 3680-71-5 | Ruxolitinib Phosphate |
| XRUX25015 | 4-Chloropyrrolo[2,3-d]Pyrimidine | 3680-69-1 | Ruxolitinib Phosphate |
| XRUX25016 | 4-Methyl-7H-pyrrolo[2,3-d]pyrimidine | 945950-37-8 | Ruxolitinib Phosphate |
| XRUX25017 | (R)-3-cyclopentyl-3-hydrazinylpropanenitrile L-tartaric acid salt dihydrate | 2761879-36-9 | Ruxolitinib Phosphate |
| XRUX25018 | 7H-Pyrrolo[2,3-d]pyrimidin-4-ol | 1194710-85-4 | Ruxolitinib Phosphate |
| XSIL25011 | (R)-3-(5-(2-Aminopropyl)-7-Cyanoindolin-1-yl)Propyl Benzoate (2R,3R)-2,3-Dihydroxysuccinate | 239463-85-5 | Silodosin |
| XSPA25011 | (2-(N-(4,5-Dimethylisoxazol-3-yl)-N-(Methoxymethyl)Sulfamoyl)Phenyl)Boronic Acid | 415697-58-4 | Sparsentan |
| XSPA25012 | 4-Bromo-3-(Ethoxymethyl)Benzaldehyde | 837408-71-6 | Sparsentan |
| XSPA25013 | N-(4,5-Dimethyl-3-isoxazolyl)-2'-(ethoxymethyl)-4'-formyl-N-(methoxymethyl)[1,1'-biphenyl]-2-sulfonamide | 1026913-68-7 | Sparsentan |
| XSPA25014 | N-(4,5-dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-4'-(hydroxymethyl)-N-(methoxymethyl)-[1,1'-biphenyl]-2-sulfonamide | 1098924-76-5 | Sparsentan |
| XSUN25011 | 5-Formyl-2,4-Dimethyl-1H-Pyrrole-3-Carboxylic Acid | 253870-02-9 | Sunitinib |
| XSUN25012 | 5-Fluoro-2-Oxindole | 56341-41-4 | Sunitinib |
| XTEN25011 | (S)-4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline | 1870821-29-6 | Tenapanor |
| XTEN25012 | 4-(3-bromophenyl)-6,8-dichloro-2-methyl-1,2,3,4-tetrahydroisoquinoline | 543737-10-6 | Tenapanor |
| XTEN25013 | N-Methyl-2,4-dichlorobenzylamine | 5013-77-4 | Tenapanor |
| XTEN25014 | Tert-Butyl 2-[2-(2-Aminoethoxy)Ethoxy]Ethylcarbamate | 153086-78-3 | Tenapanor |
| XTIC25021 | 3-Thienylmalonic Acid | 21080-92-2 | Ticarcillin |
| XTIC25022 | 2,2-Dimethyl-5-(3-Thienyl)-4,6-Dione-1,3-Dioxane | 61857-83-8 | Ticarcillin |
| XTOF25011 | Cis-N-Benzyl-3-Methylamino-4-Methyl-Piperidine Bis-(Hydrochloride) | 1062580-52-2 | Tofacitinib Citrate |
| XTOF25012 | Bis[(3R,4R)-1-Benzyl-N,4-Dimethylpiperidin-3-Amine]di-p-Toluyl-L-Tartrate | 477600-71-8 | Tofacitinib Citrate |
| XTOF25013 | 2,4-Dichloro-7H-Pyrrolo[2,3-d]Pyrimidine | 90213-66-4 | Tofacitinib Citrate |
| XTOF25014 | 4-Chloro-7-(4-Methylphenylsulfonyl)-7H-Pyrrolo[2,3-d]Pyrimidine | 479633-63-1 | Tofacitinib Citrate |
| XTOF25015 | N-Methyl-N-[(3R,4R)-4-Methyl-1-(Phenylmethyl)-3-Piperidinyl]-7-[(4-Methylphenyl)Sulfonyl]-7H-Pyrrolo[2,3-d]Pyrimidin-4-Amine | 923036-30-0 | Tofacitinib Citrate |
| XUPA26011 | 2,2,2-trifluoroethanamine;hydrochloride | 373-88-6 | Upadacitinib |
| XVAR25011 | Vardenafil | 224785-90-4 | Vardenafil |
| XVAR25012 | 2-(2-ethoxyphenyl)-5-methyl-7-propyl-3H-imidazolo[5,1-F][1,2,4]triazin-4-one | 224789-21-3 | Vardenafil |
| XVAR25013 | 2-Ethoxybenzamidine hydrochloride | 18637-00-8 | Vardenafil |
| XVAR25014 | 2-Butyrylaminopropinicacid | 59875-04-6 55930-29-5 | Vardenafil |
| XVER25011 | 5-Fluoro-1H-pyrazolo[3,4-b]pyridin-3-Amine | 1034667-22-5 | Vericiguat |
| XVER25012 | 5-Fluoro-3-iodo-1H-pyrazolo[3,4-b]pyridine | 1350653-23-4 | Vericiguat |
| XVER25013 | 5-Fluoro-1-(2-fluorobenzyl)-3-iodo-1H-pyrazolo[3,4-b]pyridine | 1350653-24-5 | Vericiguat |
| XVER25014 | 4-Amino-2,6-dihydroxypyrimidine | 873-83-6 | Vericiguat |
| XVER25015 | 2-Chloro-5-nitro-4,6-pyrimidinediamine | 408352-74-9 | Vericiguat |
| XVEN25011 | 1H-Pyrrolo[2,3-B]Pyridin-5-ol | 98549-88-3 | Venetoclax |
| XVEN25012 | (2-(4-Chlorophenyl)-4,4-Dimethylcyclohex-1-Enyl)Methanol | 1228780-51-5 | Venetoclax |
| XVEN25013 | Methyl 2-[(1H-Pyrrolo[2,3-b]Pyridin-5-Yl)Oxy]-4-Fluorobenzoate | 1235865-75-4 | Venetoclax |
| XVEN25014 | 3-Nitro-4-[[(Tetrahydropyran-4-yl)Methyl]Amino]Benzenesulfonamide | 1228779-96-1 | Venetoclax |
| XVEN25015 | 1-[[2-(4-Chlorophenyl)-4,4-Dimethylcyclohex-1-Enyl]Methyl]Piperazine | 1228780-72-0 | Venetoclax |
| XVEN25016 | 4'-Chloro-5,5-Dimethyl-3,4,5,6-Tetrahydro-[1,1'-Biphenyl]-2-Carbaldehyde | 1228837-05-5 | Venetoclax |
| XVEN25017 | 1-((4¡¯-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1¡¯-biphenyl]-2-yl)methyl)piperazinedihydrochloride | 1628047-87-9 | Venetoclax |
| XVER25011 | Ethyl 3-amino-1H-pyrrole-2-carboxylate hydrochloride | 252932-49-3 | Verdiperstat |
| XVON25011 | 5-(2-Fluorophenyl)-1H-Pyrrole-3-Carboxaldehyde | 881674-56-2 | Vonoprazan Fumarate |
| XVON25012 | 3-Pyridine Sulfonyl Chloride | 16133-25-8 | Vonoprazan Fumarate |
| XZAS25011 | 5,6-Diaminopyridine-3-Carboxylic Acid Methyl Ester | 104685-76-9 | Zastaprazan |
| XZAS26012 | 2-(chloromethyl)-1,3-dimethylbenzene | 5402-60-8 | Zastaprazan |
| XCAA25011 | (S)-2-((tert-butoxycarbonyl)amino)-3-(pyridin-3-yl)propanoic acid | 117142-26-4 | Chiral Amio Acid |
| XCAA25012 | Boc-5-Fluoro-L-Tryptophan | 53478-53-8 | Chiral Amio Acid |
| XCAA25013 | 4-amino-N¡ä-hydroxy-1,2,5-oxadiazole-3-carboximidoyl chloride | 147085-13-0 | Chiral Amio Acid |
| XFIN25011 | 6-Fluoro-2-Pyridinesulfonamide | 124433-70-1 | Fine Chemical |
| XFIN25012 | 6-Fluoropyridine-2-sulfonyl chloride | 128583-07-3 | Fine Chemical |
| XFIN25013 | 2-Bromo-5-fluoro-4-nitroaniline | 952664-69-6 | Fine Chemical |
| XFIN25014 | tert-Butyl 2,6-dichloronicotinate | 1013647-75-0 | Fine Chemical |
| XFIN25015 | 6-Bromo-2-fluoronicotinic acid | 1214345-17-1 | Fine Chemical |
| XFIN25016 | 6-bromo-2-fluoronicotinamide | 2350291-20-0 | Fine Chemical |
| XFIN25017 | N,N-Diisopropylethylamine | 7087-68-5 | Fine Chemical |
| XFIN25018 | 2,2-dimethoxyethanamine | 22483-09-6 | Fine Chemical |
| XFIN25019 | N,N'-Diisopropylcarbodiimide | 693-13-0 | Fine Chemical |
| XFIN25020 | 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide | 1892-57-5 | Fine Chemical |
| XFIN25021 | HBTU | 94790-37-1 | Fine Chemical |
| XFIN25022 | 1-Tert-Butyl-3 ethylcarbodimide | 1433-27-8 | Fine Chemical |
| XFIN25023 | Chloro-N,N,N',N'-tetramethylformamidinium hexafluorophosphate | 94790-35-9 | Fine Chemical |
| XFIN25024 | 1-(3-Dimethylaminopropyl)-3-ethylcarbodiimide methiodide | 22572-40-3 | Fine Chemical |
| XFIN25025 | 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimidep-toluenesulfonate | 1363481-45-1 | Fine Chemical |
| XFIN25026 | Potassium;ethyl (2E)-2-cyano-2-oxidoiminoacetate | 158014-03-0 | Fine Chemical |
| XFIN25027 | [[(Z)-(1-cyano-2-ethoxy-2-oxoethylidene)amino]oxy-morpholin-4-ylmethylidene]-dimethylazanium;hexafluorophosphate | 1075198-30-9 | Fine Chemical |
| XFIN25028 | [(5-chloro-3-oxidobenzotriazol-3-ium-1-yl)-(dimethylamino)methylidene]-dimethylazanium;hexafluorophosphate | 330645-87-9 | Fine Chemical |
| XFIN25029 | Azido(tributyl)stannane | 17846-68-3 | Fine Chemical |
| XFIN25030 | N,N-diethylethanamine;trihydrofluoride | 73602-61-6 | Fine Chemical |
| XFIN25031 | N-ethyl-N-propan-2-ylpropan-2-amine;trihydrofluoride | 131600-43-6 | Fine Chemical |
| XFIN25032 | 1-[2-(dimethylamino)ethyl]-2H-tetrazole-5-thione | 61607-68-9 | Fine Chemical |
| XFIN25033 | 1-phenyl-2H-tetrazole-5-thione | 86-93-1 | Fine Chemical |
| XFIN25034 | isothiocyanatobenzene | 103-72-0 | Fine Chemical |
| XFIN25035 | Isothiocyanatoethane | 542-85-8 | Fine Chemical |
| XFIN25036 | 4-(3,4-dichlorophenyl)-3,4-dihydro-2H-naphthalen-1-one | 79560-19-3 | Fine Chemical |
| XFIN25037 | Bis(2,6-diisopropylphenyl)carbodiimide | 2162-74-5 | Fine Chemical |
| XFIN25038 | 4-Methyl-1H-1,2,4-triazole-5-thione | 24854-43-1 | Fine Chemical |
| XFIN25039 | 1,2-Dihydro-1,2,4-triazole-3-thione | 3179-31-5 | Fine Chemical |
| XFIN25040 | Dimethyl oxalate | 553-90-2 | Fine Chemical |
| XFIN26011 | 4,4,5,5-tetramethyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,3,2-dioxaborolane | 73183-34-3 | Fine Chemical |
